Well, with all the capping at 35, the delayed drill results and AVM being pumped, I am starting to think someone is negotiating to sell us out with a share swap merger valuing TGS at 35c.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
